We further investigated possible reasons why canine BRCA2 expression was reduced in tumor samples: mutations in the BRCA2 promoter region and non-sense mRNA decay (NMD) induced by PTCs that can form in splice variants. This evidence concerns the gene BRCA2 and neoplasm.